Beijing Mygenostics Co., Ltd.
Similar suppliers you may like
Capitalbio Technology Co., Ltd.
🇨🇳 China
101-200 peopleManufacturer/Service CompanyHigh-tech enterprise
Low MOQ
Shipments
127
Key customer
DOIT
Key market
🇻🇳 Vietnam
Description
Capitalbio Technology Co., Ltd. is a contract manufacturer and service company based in Beijing, China, operating as the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips. Established with 101 to 200 employees, the company integrates R&D, production, sales, and third-party independent medical laboratory services. Capitalbio Technology specializes in genetic detection and microarray technology, offering products such as Ngs Mutation Detection, Cnv-Seq Detection, Capitalbio® Microarray Scanner Luxscan™ 10K/D, Capitalbio® DNA Microarray Scanner Luxscan™ 10K, and Capitalbio® Microarray Hybridization Station. They also provide comprehensive genetic testing services, including those for hereditary cancers (e.g., BRCA1/2), blood cancer, and folic acid utilization ability. The company emphasizes independent innovation and achievement transformation, aligning with national health policies by integrating modern and traditional Chinese medicine to form a broad health industry section.
Genetic Testing of 18 Hereditary Cancer$10
Forensic Platform$10
Genetic Testing for Blood Cancer$10
Genetic Testing for Brca1/2 Targeted-Drug Guidance [ Germline + Somatic]$10
Genetic Testing for Hereditary Breast/Ovarian Cancer (BRCA1/2)$10
Folic Acid Utilization Ability Genetic Detection$10
Beijing Zhongsheng Jinyu Diagnosis Technology Co., Ltd.
🇨🇳 China
2003101-200 peopleManufacturer/Trading CompanyEstablished brand
High-tech enterprise
Industry association member
Patented technology
Description
Beijing Zhongsheng Jinyu Diagnosis Technology Co., Ltd. is a prominent high-tech enterprise based in Beijing, China, specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) and Point-of-Care Testing (POCT) solutions. Established in 2003 and supported by the Institute of Biophysics of the Chinese Academy of Sciences, the company operates as a subsidiary of the Biosino Group. It is recognized as a national high-tech enterprise and a demonstration unit for industry-research integration, having been listed on the New Third Board since 2016.
The company maintains a robust manufacturing infrastructure with six specialized POCT production lines and a workforce of approximately 100 to 200 employees. Their comprehensive product portfolio focuses on maternal and child health, nutritional assessment, and chronic disease surveillance. Key offerings include innovative diagnostic kits for bacterial vaginosis, aerobic vaginitis, bone metabolism (BAP), urinary iodine, and intestinal barrier function. Notably, their Vaginal Fluid Analysis System and various rapid-assay kits are widely utilized in over 2,000 medical institutions across China.
As an ISO 9001 and ISO 13485 certified manufacturer, Beijing Zhongsheng Jinyu Diagnosis Technology Co., Ltd. emphasizes quality and independent innovation. They provide OEM and contract manufacturing services, leveraging advanced R&D platforms in whole blood dry slice, multilayer film, and enzymatic chemical sensor technologies. Their products are designed for diverse clinical environments, ranging from hospital outpatient departments and community health centers to portable home-use testing applications.
Vaginal Fluid Analysis System$1000
